Regulation and Manipulation of Oral Type III Interferon Responses by Porphyromonas gingivalis

牙龈卟啉单胞菌对口腔 III 型干扰素反应的调节和操纵

基本信息

项目摘要

ABSTRACT This proposal addresses the nature of interferon (IFN)-based antiviral responses at the oral mucosal barrier, and the bacterial factors that impact their efficacy. IFNs are antiviral cytokines that are critical in limiting all aspects of viral infection. We found that Type III IFNs or IFN lambdas (IFN-λs) are preferentially expressed by oral epithelial cells, and IFN-λ-associated signaling confers robust, broad-spectrum, antiviral immunity at the oral mucosal barrier. Bacterial colonizers at barrier sites have the potential to modulate host susceptibility to viral infection. Consistent with this, we found that Porphyromonas gingivalis (Pg), which is associated with oral dysbiosis and periodontal disease, singularly and totally dampened all aspects of IFN signaling in response to viral agonists. The overall goal of this study is to characterize the effect of Pg-induced IFN-λ suppression on viral clearance and neutrophil function, as well as determine the relevance of IFN-λ suppression for Pg colonization. Our main hypothesis is that IFN-λ is preferentially induced at the oral mucosal barrier and confers antiviral immune protection without inducing inflammation. Further, we hypothesize that Pg disengages both homeostatic and inducible IFN-λ responses, thereby enhancing host susceptibility to oral viral infection and to chronic inflammation, as well as contributing to Pg persistence. These hypotheses will be tested in the following specific aims. Aim 1: Characterize the impact of Pg-mediated suppression of IFN-λ signaling on viral clearance in vivo. Aim 2: Determine the contribution of IFN-λ mediated regulation of neutrophil effector functions to tissue damage and persistent inflammation during oral viral infections. Aim3: Determine the role of inactivation of IFN signaling in Pg persistence during infection. This study will provide fundamental novel information on the role of Pg in the suppression of anti-microbial inflammatory responses at the oral mucosal barrier. Additionally, an increased understanding of the factors that provide antiviral resistance in the oral cavity is highly significant as a large number of viruses, including SARS-Cov2, can infect oral tissues and cause local and systemic disease.
摘要 该提案解决了在口腔粘膜屏障处基于干扰素(IFN)的抗病毒应答的性质, 影响其功效的细菌因素。干扰素是抗病毒细胞因子,在限制所有方面都至关重要 病毒感染。我们发现,III型IFN或IFN-λ s(IFN-λs)优先表达于口腔粘膜, 上皮细胞和IFN-λ相关信号传导在口腔中赋予强大的,广谱的抗病毒免疫力。 粘膜屏障屏障部位的细菌定殖者有可能调节宿主对病毒的易感性 感染与此一致,我们发现牙龈卟啉单胞菌(Pg),这是与口腔 菌群失调和牙周病,单独和完全抑制干扰素信号的所有方面,以响应 病毒激动剂。本研究的总体目标是表征Pg诱导的IFN-λ抑制对IFN-γ表达的影响。 病毒清除和中性粒细胞功能,以及确定IFN-λ抑制与Pg 殖民化我们的主要假设是IFN-λ优先在口腔粘膜屏障被诱导, 抗病毒免疫保护而不诱导炎症。此外,我们假设PG使两者都脱离 稳态和诱导型IFN-λ应答,从而增强宿主对口腔病毒感染的易感性, 慢性炎症,以及有助于Pg持久性。这些假设将在下面进行检验 具体目标。目的1:表征Pg介导的IFN-λ信号转导抑制对病毒清除的影响 in vivo.目的2:确定IFN-λ介导的中性粒细胞效应功能调节对组织的贡献。 口腔病毒感染期间的损伤和持续炎症。目的3:确定IFN灭活的作用 感染期间Pg持续存在的信号传导。这项研究将提供关于以下作用的基本新信息: 前列腺素抑制口腔黏膜屏障抗微生物炎症反应。此外, 增加对口腔中提供抗病毒耐药性的因素的理解, 包括SARS-Cov 2在内的大量病毒可感染口腔组织并引起局部和全身性疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Juhi Bagaitkar其他文献

Juhi Bagaitkar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Juhi Bagaitkar', 18)}}的其他基金

A T.fosythia-derived protease inhibitor in periodontal health and disease
一种源自 T.fosythia 的蛋白酶抑制剂对牙周健康和疾病的影响
  • 批准号:
    10447716
  • 财政年份:
    2021
  • 资助金额:
    $ 43.12万
  • 项目类别:
A T.fosythia-derived protease inhibitor in periodontal health and disease
一种源自 T.fosythia 的蛋白酶抑制剂对牙周健康和疾病的影响
  • 批准号:
    10279103
  • 财政年份:
    2021
  • 资助金额:
    $ 43.12万
  • 项目类别:
A T.fosythia-derived protease inhibitor in periodontal health and disease
一种源自 T.fosythia 的蛋白酶抑制剂对牙周健康和疾病的影响
  • 批准号:
    10673635
  • 财政年份:
    2021
  • 资助金额:
    $ 43.12万
  • 项目类别:
Redox Regulation of Gingival Inflammation
牙龈炎症的氧化还原调节
  • 批准号:
    9885641
  • 财政年份:
    2019
  • 资助金额:
    $ 43.12万
  • 项目类别:
Redox Regulation of Gingival Inflammation
牙龈炎症的氧化还原调节
  • 批准号:
    10579090
  • 财政年份:
    2019
  • 资助金额:
    $ 43.12万
  • 项目类别:
Redox Regulation of Gingival Inflammation
牙龈炎症的氧化还原调节
  • 批准号:
    10530608
  • 财政年份:
    2019
  • 资助金额:
    $ 43.12万
  • 项目类别:
Redox Regulation of Gingival Inflammation
牙龈炎症的氧化还原调节
  • 批准号:
    10308384
  • 财政年份:
    2019
  • 资助金额:
    $ 43.12万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 43.12万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 43.12万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.12万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.12万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 43.12万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.12万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 43.12万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 43.12万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 43.12万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.12万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了